Dr. Steven Ross Brant, MD

Dr. Brant practices at Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health.

Dr. Brant's NPI, 1386601953, was assigned on April 27, 2006. Dr. Brant graduated from University of Florida College of Medicine in 1986. Dr. Brant holds New Jersey license 25MA10198400.

Dr. Brant's primary practice is Robert Wood Johnson University Hospital, at One Robert Wood Johnson Place, New Brunswick, NJ 08901 in Middlesex County. The practice phone is (732) 828-3000. Dr. Brant also practices at Robert Wood Johnson University Hospital - New Brunswick, 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901.

Dr. Brant's primary practice is Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health. The medical group on file is Rutgers-RWJ Scleroderma Program.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brant practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Brant's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Brant's licenses on file in 2 states: New Jersey and Maryland.

Dmand AI lists chronic inflammatory bowel disease (IBD), colonoscopy, esophagus, stomach, or upper small intestine surgery, fatty liver, gastroenteritis, intestinal diverticulosis, intestinal or bowel obstruction and irritable bowel syndrome (IBS) among the conditions Dr. Brant treats.

CMS data shows 97 Medicare services from Dr. Brant across 4 procedure codes in 2024, for 115 Medicare patients. Medicare paid $9,738 for them.

CMS counts 115 Medicare patients who saw Dr. Brant in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Brant's median patient age at 48, with 47% women.

In 2024, Dr. Brant wrote 58 Medicare Part D claims for 28 patients. 83% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $139 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Brant for performance year 2024, reported as part of a group. Dr. Brant accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 22 procedures of colonoscopy by Dr. Brant, more than 49% of the clinicians it reports for that procedure.

Dmand AI links 86 papers to Dr. Brant, published from 2003 to 2024. 2016 was the busiest year, with 4. The most frequent topics are Crohn Disease, Genetic Predisposition to Disease and Colitis, Ulcerative. Dr. Brant has published most often in Inflamm Bowel Dis. Dr. Brant's most frequent co-authors are Dermot P. McGovern, MD, PhD, Mark A. Silverberg, MD and Judy Cho, MD.

CMS Open Payments shows 7 general payments to Dr. Brant from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $129.

Dmand AI lists 2 awards for Dr. Brant, most recently CMS Stage 1 EHR in 2014.

Dr. Brant graduated from University of Florida College of Medicine in 1986.

Dr. Brant is in network with 15 carriers, including Aetna, Elevance and Horizon Blue Cross Blue Shield of New Jersey. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.